Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist

被引:18
作者
Omori, Naoki [1 ]
Kouyama, Naoki [1 ]
Yukimasa, Akira [1 ]
Watanabe, Kana [1 ]
Yokota, Yasunori [1 ]
Tanioka, Hideki [1 ]
Nambu, Hirohide [1 ]
Yukioka, Hideo [1 ]
Sato, Norihito [2 ]
Tanaka, Yukari [2 ]
Sekiguchi, Kazutaka [2 ]
Okuno, Takayuki [1 ]
机构
[1] Shionogi & Co Ltd, Med Res Labs, Toyonaka, Osaka 5610825, Japan
[2] Shionogi & Co Ltd, Drug Dev Res Labs, Toyonaka, Osaka 5610825, Japan
关键词
Obesity; NPY Y5 receptor antagonist; GPCR; Benzoxazole; Hit to lead; RECEPTOR ANTAGONISTS; POTENT; DISCOVERY; DESIGN;
D O I
10.1016/j.bmcl.2012.01.027
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report a hit to lead study on a novel benzoxazole NPY Y5 antagonist. Starting from HTS hit 1, structure-activity relationships were developed. Compound 12 showed reduction of food intake and a tendency to suppress body weight gain over the 21-day experimental period. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2020 / 2023
页数:4
相关论文
共 23 条
[1]   Synthesis and structure-activity relationship of N-(3-azabicyclo[3.1.0]hex-6-ylmethyl)-5-(2-pyridinyl)-1,3-thiazol-2-amines derivatives as NPY Y5 antagonists [J].
Biagetti, Matteo ;
Leslie, Colin Philip ;
Mazzali, Angelica ;
Seri, Catia ;
Pizzi, Domenica Antonia ;
Bentley, Jonathan ;
Genski, Thorsten ;
Di Fabio, Romano ;
Zonzini, Laura ;
Caberlotto, Laura .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (16) :4741-4744
[2]   Y-receptor subtypes - How many more? [J].
Blomqvist, AG ;
Herzog, H .
TRENDS IN NEUROSCIENCES, 1997, 20 (07) :294-298
[3]  
Edwards PJ, 2011, CURR MED CHEM, V18, P3116
[4]   Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y [J].
Erickson, JC ;
Hollopeter, G ;
Palmiter, RD .
SCIENCE, 1996, 274 (5293) :1704-1707
[5]   Introduction to the reviews on neuropeptide Y [J].
Gehlert, DR .
NEUROPEPTIDES, 2004, 38 (04) :135-140
[6]   A receptor subtype involved in neuropeptide-Y-induced food intake [J].
Gerald, C ;
Walker, MW ;
Criscione, L ;
Gustafson, EL ;
BatzlHartmann, C ;
Smith, KE ;
Vaysse, P ;
Durkin, MM ;
Laz, TM ;
Linemeyer, DL ;
Schaffhauser, AO ;
Whitebread, S ;
Hofbauer, KG ;
Taber, RI ;
Branchek, TA ;
Weinshank, RL .
NATURE, 1996, 382 (6587) :168-171
[7]   The NPY system in stress, anxiety and depression [J].
Heilig, M .
NEUROPEPTIDES, 2004, 38 (04) :213-224
[8]   CLONED HUMAN NEUROPEPTIDE-Y RECEPTOR COUPLES TO 2 DIFFERENT 2ND MESSENGER SYSTEMS [J].
HERZOG, H ;
HORT, YJ ;
BALL, HJ ;
HAYES, G ;
SHINE, J ;
SELBIE, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :5794-5798
[9]   Discovery of novel orally active ureido NPYY5 receptor antagonists [J].
Li, Guoqing ;
Stamford, Andrew W. ;
Huang, Ying ;
Cheng, Kuo-Chi ;
Cook, John ;
Farley, Constance ;
Gao, Jun ;
Ghibaudi, Lorraine ;
Greenlee, William J. ;
Guzzi, Mario ;
van Heek, Margaret ;
Hwa, Joyce J. ;
Kelly, Joe ;
Mullins, Deborra ;
Parker, Eric M. ;
Wainhaus, Sam ;
Zhang, Xiaoping .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) :1146-1150
[10]   Facile rearrangements of alkynylamino heterocycles with noble metal cations [J].
Lok, R ;
Leone, RE ;
Williams, AJ .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (10) :3289-3297